© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

Erlandsson to leave Anthropocene Fixed Income Institute, return to AP4

Founder of climate investing think tank wants to apply ideas as bond investor
The yield was ultra high but Congo had little room to manoeuvre

Missing mandates need not be so miserable

No one wins playing the blame game

Bitcoin ABS edges forward as price plunge turns collateral to cash

When loans' LTVs hit 80%, Bitcoin stakes are liquidated in seconds
The yield was ultra high but Congo had little room to manoeuvre
Sub-sections
  • Fresenius, the German healthcare company, pushed ahead with a €1bn dual tranche no-grow trade on Monday, despite an issuer in another sector pulling its deal as wider markets plummeted.
  • German hospital operator Asklepios Kliniken launched a Schuldschein on Monday with an initial target of €200m. Investors have doubled down on their interest in pharmaceutical firms this year and throughout the pandemic, prompting a substantial increase in the market’s exposure to the sector.
  • Rolls-Royce, the UK maker of aircraft engines, has confirmed it is considering holding a £2.5bn ($3.19bn) equity raise, but buy-side sources were struggling to make the investment case for the company given the uncertainty over its future. Its stock fell 10% on Monday on the announcement and fears that the UK will return to a lockdown to stop the dramatic rise in Covid-19 cases.